Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 4Terminated 1No longer available 1

Sponsor Class

OTHER 19INDUSTRY 6OTHER_GOV 1

Study Type

Interventional 5Expanded_access 1

Sponsor

Cancer Type

Genitourinary 13Thoracic 10Gastrointestinal 7Dermatologic 6CNS 6Breast 6Other hematologic neoplasm 4Lymphoid 4Plasma cell 3Head & Neck 2Sarcoma 1Other neoplasm 1Other 1Myeloid 1Endocrine 1

Conditions

Glioblastoma 473Brain Neoplasms 306Glioma 257Neoplasms 122Astrocytoma 88Carcinoma, Non-Small-Cell Lung 77Breast Neoplasms 70Neuroblastoma 65Central Nervous System Neoplasms 61Melanoma 58Recurrence 46Lung Neoplasms 45Pancreatic Neoplasms 41Oligodendroglioma 37Ovarian Neoplasms 36Colorectal Neoplasms 36Neoplasm Metastasis 33Sarcoma 32Medulloblastoma 28Stomach Neoplasms 27Gliosarcoma 27Lymphoma 25Prostatic Neoplasms 24Head and Neck Neoplasms 24Neurofibromatosis 1 22Rhabdomyosarcoma 21Esophageal Neoplasms 19Diffuse Intrinsic Pontine Glioma 19Cholangiocarcinoma 19Carcinoma, Hepatocellular 19

Interventions

fluciclovine F-18 2pembrolizumab 1Oncolytic Virotherapy 1Antibodies, Monoclonal 1ABT-414 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Disease × CNS × Clear all
NCT04410133 2025-08-28

REVELATE

Blue Earth Diagnostics

Phase 3 Completed
151 enrolled 29 charts
CNS

Brain Neoplasms, Disease

NCT04410367 2025-07-20

PURSUE

Blue Earth Diagnostics

Phase 2 Completed
23 enrolled 10 charts
CNS

Brain Neoplasms, Disease

NCT02798406 2021-07-15

CAPTIVE

DNAtrix, Inc.

Phase 2 Completed
49 enrolled
CNSSarcoma

Brain Neoplasms, Disease, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Nervous System Diseases, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Gliosarcoma

NCT03123952 2019-07-15

Expanded Access to ABT-414

AbbVie

No longer available
CNS

Disease, Glioblastoma

NCT00126412 2019-05-31

Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma

GE Healthcare

Phase 3 Completed
251 enrolled
CNSEndocrine

Disease, Neuroblastoma, Pheochromocytoma

NCT01898273 2015-09-09

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

Cellectar Biosciences, Inc.

Phase 2 Terminated
7 enrolled
CNS

Disease, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡